To study the effectiveness of haridradi yog matra basti in prameha

Randomized controlled clinical trial to evaluate the efficacy of haridradi yog matra basti in prameha w.s.r. to diabetes mellitus type II - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/112227

Enrollment

Registered

2026-06-08

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Recently diagnosed patients of Type 2 Diabetes Mellitus. 2) 60 patients of irrespective gender will be included and who are willing to take treatment. 3) Patient of age group between 30-60 years of both sexes will be selected. 4) Patients with fasting blood sugar level below 200 mg/dl and post Prandial upto 250 mg/dl. 5) Patients with Glycosylated heamoglobin i.e. HbA1C value more than 6 % and less than 10 %. 6) Patient showing signs and symtoms of prameha or diabetes mellitus i.e prabhut mutrata, nakta mutrata, pipasa vriddhi kshudha vridhhi, General debility etc will be selected for study.

Exclusion criteria

Exclusion criteria: 1) Patient having Sahaj Madhumeha (Insulin Dependent Diabetes Mellitus). 2) Patients having any severe systemic disease. 3) K/C/O Ketoacidosis, Diabetic coma, acute infections anywhere in the body and Gangrene. 4) Patients with any major systemic diseases like Carcinoma, Tuberculosis etc. 5) K/C/O Immunocompromised patients or patients on immunosuppressive drugs. 6) K/C/O Neuropathic ulcer, Peripheral vascular diseases.

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of haridradi yog matra basti in management of prameha w.s.r. to diabeties mellitus reduction in fasting blood sugar reduction in postprandial blood sugar improvement in the symptoms of pramehaTimepoint: 9th day	—

Secondary

Measure	Time frame
where the trial group stands in comparison with control groupTimepoint: 18 months	—

Countries

India

Contacts

Public ContactDr Tanuja Sanjay Gaikwad

Late Kedari Redekar Ayurvedic Mahavidyalaya

gaikwadtanuja14@gmail.com7588335343

Outcome results